NmeCas9 is an intrinsically high-fidelity genome-editing platform https://t.co/APbGBLDehK
RT @_atanas_: NmeCas9 is an intrinsically high-fidelity genome-editing platform. - PubMed - NCBI https://t.co/7csuOjKYsa
NmeCas9 is an intrinsically high-fidelity genome-editing platform. - PubMed - NCBI https://t.co/7csuOjKYsa
RT @danielxingao: Finally our paper is online! It’s quite a journey to characterize the genome-wide targeting specificity of NmeCas9 nuclea…
RT @danielxingao: Finally our paper is online! It’s quite a journey to characterize the genome-wide targeting specificity of NmeCas9 nuclea…
RT @danielxingao: Finally our paper is online! It’s quite a journey to characterize the genome-wide targeting specificity of NmeCas9 nuclea…
RT @BioMickWatson: NmeCas9 is an intrinsically high-fidelity genome-editing platform https://t.co/fwKSPG1bdM
NmeCas9 is an intrinsically high-fidelity genome-editing platform | Genome Biology | Full Text https://t.co/3cB56dOJ2R https://t.co/QW9KEqdtZ9 The development of CRISPR genome editing has transformed biomedical research. Most applications reported thus f
RT @GenomeBiology: Amarani, Gao, Sontheimer and co find that Cas9 from Neisseria meningitidis shows much lower rates of off-target editing…
RT @danielxingao: Finally our paper is online! It’s quite a journey to characterize the genome-wide targeting specificity of NmeCas9 nuclea…
RT @GenomeBiology: Amarani, Gao, Sontheimer and co find that Cas9 from Neisseria meningitidis shows much lower rates of off-target editing…
Amarani, Gao, Sontheimer and co find that Cas9 from Neisseria meningitidis shows much lower rates of off-target editing compared with the commonly-used one from Streptococcus pyogenes https://t.co/c7gK5qW0EU
RT @danielxingao: Finally our paper is online! It’s quite a journey to characterize the genome-wide targeting specificity of NmeCas9 nuclea…
Nice work by @danielxingao, @SontheimerLab, and all involved. RT
RT @danielxingao: Finally our paper is online! It’s quite a journey to characterize the genome-wide targeting specificity of NmeCas9 nuclea…
RT @BioMickWatson: NmeCas9 is an intrinsically high-fidelity genome-editing platform https://t.co/fwKSPG1bdM
RT @BioMickWatson: NmeCas9 is an intrinsically high-fidelity genome-editing platform https://t.co/fwKSPG1bdM
NmeCas9 is an intrinsically high-fidelity genome-editing platform https://t.co/fwKSPG1bdM
NmeCas9 is an intrinsically high-fidelity genome-editing platform https://t.co/rjRsYvzpNy
Finally our paper is online! It’s quite a journey to characterize the genome-wide targeting specificity of NmeCas9 nuclease using both GUIDE-seq and SITE-seq. We have been very grateful for the collaboration we had with UMMS colleagues and @CaribouBio ht